Skip to contentO
Oragenics Inc
O
OGENOragenics Inc Q1 2018 · 10-Q
Revenue$0.00$0.00— vs Q1 2017 Net Income-$2.12M-$2.12MN/M vs Q1 2017 EPS Diluted-$0.42-$0.42N/M vs Q1 2017 Operating Income-$2,121,704N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 15, 2018 · 45 d after period end